Long-Term Neurological Effects of Ebola Identified in Study of Survivors

A study published in JAMA Neurology has found that Ebola survivors in Liberia continue to experience significant neurological and cognitive impairments up to seven years after infection, highlighting the need for long-term medical follow-up. The research, conducted between 2015 and 2023, followed 229 individuals, including 148 survivors and 81 uninfected contacts, and revealed persistent issues such as memory loss, irritability, and concentration difficulties among survivors.

What Are the Long-Term Neurological Effects of Ebola?

During the acute phase of Ebola infection, survivors often reported headaches, altered consciousness, and rare stroke-like symptoms or encephalitis. Long-term follow-up showed that most survivors experienced improvements, but over 50% still faced challenges such as memory loss, irritability, and difficulty concentrating five or more years post-infection. The study also found that those with more severe initial illness had fewer long-term neurological issues, suggesting that the body’s immune response, rather than the virus itself, may drive these effects. High levels of anti-Ebola antibodies were linked to increased neurological symptoms, according to the researchers.

Why Is This Study Significant?

The findings underscore the importance of neurologic and psychological care for Ebola survivors, beyond acute treatment. “Ebola is a neurotropic virus, meaning it directly affects the nervous system and can have lasting consequences,” said Dr. Sarah M. Smith, a neurologist at the University of California, San Francisco, who was not involved in the study. “This research adds to growing evidence that survivors require ongoing monitoring to address these hidden scars.”

What Is the Current Status of the Ebola Outbreak in the DRC?

The Democratic Republic of the Congo (DRC) is experiencing a surge in Ebola cases, with 808 confirmed infections and 192 deaths as of May 2024, according to the DRC Ministry of Health. The virus spreads through direct contact with bodily fluids or contaminated objects, and a lack of diagnostic capacity has complicated efforts to track the outbreak. Bruno Michon, head of operations for the International Federation of Red Cross and Red Crescent Societies, warned that “the peak is not behind us but ahead,” citing challenges in containment and public trust.

What Treatments Are Available for Ebola?

Currently, there is no FDA-approved specific treatment for Ebola. Supportive care, including rehydration and symptom management, improves survival rates. Experimental therapies, such as monoclonal antibodies and antiviral drugs, are under investigation. The World Health Organization (WHO) emphasizes that early detection and isolation remain critical to curbing transmission.

How Can Long-Term Effects Be Addressed?

Researchers recommend integrating routine screenings for neurological symptoms—such as headaches, memory issues, or mood changes—into post-Ebola care. “These assessments should be part of standard follow-up, especially in regions where Ebola is endemic,” said Dr. James A. Johnson, an infectious disease specialist at the Centers for Disease Control and Prevention. “Ignoring these long-term impacts risks leaving survivors with untreated disabilities.”